|
|
|
 |
| September 15, 2005 |
San Francisco
Chronicle, "Vioxx Judge Reprimands Merck
Lawyer" |
The
judge hearing a product liability suit against Merck & Co.,
the manufacturer of painkiller Vioxx, reprimanded the
drug maker's lead lawyer Thursday for violating pretrial
instructions barring comments about lawyers in front
of the jury.
Threatening to declare
a mistrial, Superior Court Judge Carol E. Higbee said Merck lawyer Diane Sullivan
had made repeated negative references about attorneys in her opening statement
to jurors Wednesday, despite being told beforehand not to do so.
"It's simply playing
to the bias of jurors ... a certain perception that there are too many lawsuits
and that it's causing society problems," Higbee said.
In Wednesday's opening,
Sullivan made reference to plaintiff Frederick "Mike" Humeston being "surrounded
by lawyers" and later criticized Humeston's attorneys' interpretation of
evidence by saying, "That's not science, that's lawyering, lawyering, lawyering."
The start of testimony
Thursday was delayed by Higbee's criticism and a dispute over whether Whitehouse
Station, N.J.-based Merck would be allowed to admit into evidence a key 2005
memo from a Food and Drug Administration advisory committee.
Humeston, a 60-year-old
postal worker from Boise, Idaho, alleges Vioxx caused him to suffer a heart attack
four years ago. His lawyers told jurors on Wednesday, the first day of testimony,
that Merck rushed the product onto the market, ignored evidence of problems with
some patients and didn't warn doctors or users that Vioxx could increase the
risk of heart attacks and strokes.
Merck withdrew the popular
arthritis and pain treatment from the market in September 2004 after its own
research showed Vioxx doubled risk of heart attack and stroke after 18 months'
use. |
|
| Lieff
Cabraser: Experienced Vioxx Injury Lawyers |
| Founded
in 1972, Lieff Cabraser Heimann & Bernstein,
LLP is an over-fifty attorney law firm with
offices in San Francisco, New York and Nashville.
In each of the last five years, the National
Law Journal has recognized
Lieff Cabraser as one of the top plaintiffs law
firms in America. |
| For
our personal injury Vioxx cases, we bring a
team of experienced lawyers. In addition,
we have on staff multiple nurses, legal assistants,
scientific analysts and case clerks to assist
our Vioxx attorneys. Learn more about advantages
we offer patients with Vioxx problems and
injuries. |
|
|
|
We
have a nationwide team of experienced
injury Vioxx lawyers assigned to Vioxx
trials. |
|
We
provide individual attentive service. Learn
more about our firm. |
|
We
have retained the leading national
medical experts on Vioxx and have
a staff of nurses to assist the
prosecution of the claims of our
clients. |
|
|
|
| We
have been contacted by thousands of Vioxx drug patients
nationwide as part of the Vioxx litigation. We have represented
patients who ingested prescription drugs with dangerous,
undisclosed side effects in personal injury lawsuits
across America, including residents of Alaska, Alabama,
Arkansas, Arizona, California, Colorado, Connecticut,
Delaware, Florida, Georgia, Hawaii, Idaho, Illinois,
Indiana, Kansas, Kentucky, Louisiana, Massachusetts,
Maryland, Maine, Michigan, Minnesota, Missouri, Montana,
North Carolina, North Dakota, Nebraska, New Hampshire,
New Jersey, New Mexico, Nevada, New York, Ohio, Oklahoma,
Oregon, Pennsylvania, Rhode Island, South Dakota, Tennessee,
Texas, Utah, Virginia, Vermont, Washington, Wisconsin,
West Virginia and Wyoming. |
| Persons
living outside the United States who have been injured
by an American product manufactured may also in certain
cases file Vioxx lawsuits for compensation for heart
attacks and strokes in United States courts. |
|
|
|
|
|
Lieff
Cabraser Heimann & Bernstein, LLP |
|
|
|
|
|
|
| Trademark
Notice |
| "Vioxx"
is a registered trademark of Merck. Lieff Cabraser Heimann
& Bernstein, LLP is in no way affiliated with Merck,
and the Vioxx trademark is used solely for informational
purposes. |
|
|
|
|
Copyright © 2008 Lieff Cabraser Heimann & Bernstein, LLP |
|
|
|
|
Vioxx
Recall: The international prescription
drug company Merck announced in September
2004 the worldwide withdrawal of the arthritis
medication Rofecoxib, sold in most countries
under the brand name Vioxx, because a study
showed an increased risk of heart attack
and stroke.
Vioxx
Trial: Patients who have suffered
injuries due to Vioxx have filed litigation
against Merck for selling Vioxx even though
Merck allegedly was aware of Vioxx's dangerous
side effects. |
|
|
|
|